Fluorine in PDB 4bfs: Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
Enzymatic activity of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
All present enzymatic activity of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A):
2.7.1.33;
Protein crystallography data
The structure of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A), PDB code: 4bfs
was solved by
C.Bjorkelid,
T.Bergfors,
T.A.Jones,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
28.74 /
2.90
|
Space group
|
P 31 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.280,
105.280,
90.800,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
19.7 /
24.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
(pdb code 4bfs). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A), PDB code: 4bfs:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 4bfs
Go back to
Fluorine Binding Sites List in 4bfs
Fluorine binding site 1 out
of 4 in the Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:0.0
occ:1.00
|
FAE
|
A:ZVS501
|
0.0
|
0.0
|
1.0
|
CBF
|
A:ZVS501
|
1.3
|
95.2
|
1.0
|
FAG
|
A:ZVS501
|
2.1
|
96.5
|
1.0
|
FAF
|
A:ZVS501
|
2.2
|
100.0
|
1.0
|
CBA
|
A:ZVS501
|
2.3
|
87.8
|
1.0
|
CAK
|
A:ZVS501
|
2.6
|
81.0
|
1.0
|
O
|
A:HOH2002
|
3.5
|
35.3
|
1.0
|
CAO
|
A:ZVS501
|
3.5
|
67.5
|
1.0
|
CAZ
|
A:ZVS501
|
3.6
|
79.3
|
1.0
|
CG1
|
A:VAL99
|
3.7
|
33.2
|
1.0
|
CAM
|
A:ZVS501
|
3.8
|
74.5
|
1.0
|
CAI
|
A:ZVS501
|
4.0
|
80.9
|
1.0
|
O
|
A:HOH2003
|
4.3
|
42.2
|
1.0
|
CAW
|
A:ZVS501
|
4.4
|
75.9
|
1.0
|
NE2
|
A:HIS179
|
4.4
|
52.7
|
1.0
|
CG2
|
A:VAL99
|
4.4
|
30.6
|
1.0
|
CB
|
A:VAL99
|
4.7
|
31.7
|
1.0
|
OAC
|
A:ZVS501
|
4.7
|
74.9
|
1.0
|
CAJ
|
A:ZVS501
|
4.7
|
72.7
|
1.0
|
CAY
|
A:ZVS501
|
4.7
|
66.3
|
1.0
|
CD2
|
A:HIS179
|
4.7
|
49.6
|
1.0
|
CAH
|
A:ZVS501
|
4.9
|
77.1
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 4bfs
Go back to
Fluorine Binding Sites List in 4bfs
Fluorine binding site 2 out
of 4 in the Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:100.0
occ:1.00
|
FAF
|
A:ZVS501
|
0.0
|
100.0
|
1.0
|
CBF
|
A:ZVS501
|
1.3
|
95.2
|
1.0
|
FAG
|
A:ZVS501
|
2.2
|
96.5
|
1.0
|
FAE
|
A:ZVS501
|
2.2
|
0.0
|
1.0
|
CBA
|
A:ZVS501
|
2.4
|
87.8
|
1.0
|
CAZ
|
A:ZVS501
|
3.2
|
79.3
|
1.0
|
OAC
|
A:ZVS501
|
3.2
|
74.9
|
1.0
|
CAK
|
A:ZVS501
|
3.3
|
81.0
|
1.0
|
CD2
|
A:HIS179
|
3.3
|
49.6
|
1.0
|
NE2
|
A:HIS179
|
3.5
|
52.7
|
1.0
|
CAW
|
A:ZVS501
|
3.5
|
75.9
|
1.0
|
CAO
|
A:ZVS501
|
3.8
|
67.5
|
1.0
|
OAU
|
A:ZVS501
|
4.3
|
66.1
|
1.0
|
CAJ
|
A:ZVS501
|
4.5
|
72.7
|
1.0
|
CAI
|
A:ZVS501
|
4.5
|
80.9
|
1.0
|
NAT
|
A:ZVS501
|
4.6
|
68.9
|
1.0
|
CG
|
A:HIS179
|
4.6
|
48.0
|
1.0
|
CAY
|
A:ZVS501
|
4.6
|
66.3
|
1.0
|
CE1
|
A:HIS179
|
4.7
|
48.2
|
1.0
|
CAM
|
A:ZVS501
|
4.8
|
74.5
|
1.0
|
CAH
|
A:ZVS501
|
5.0
|
77.1
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 4bfs
Go back to
Fluorine Binding Sites List in 4bfs
Fluorine binding site 3 out
of 4 in the Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:96.5
occ:1.00
|
FAG
|
A:ZVS501
|
0.0
|
96.5
|
1.0
|
CBF
|
A:ZVS501
|
1.3
|
95.2
|
1.0
|
FAE
|
A:ZVS501
|
2.1
|
0.0
|
1.0
|
FAF
|
A:ZVS501
|
2.2
|
100.0
|
1.0
|
CBA
|
A:ZVS501
|
2.3
|
87.8
|
1.0
|
CAW
|
A:ZVS501
|
2.9
|
75.9
|
1.0
|
CAZ
|
A:ZVS501
|
2.9
|
79.3
|
1.0
|
OAC
|
A:ZVS501
|
3.3
|
74.9
|
1.0
|
CAO
|
A:ZVS501
|
3.4
|
67.5
|
1.0
|
NAT
|
A:ZVS501
|
3.4
|
68.9
|
1.0
|
NAS
|
A:ZVS501
|
3.5
|
70.4
|
1.0
|
CAK
|
A:ZVS501
|
3.5
|
81.0
|
1.0
|
CBC
|
A:ZVS501
|
3.8
|
71.1
|
1.0
|
NAR
|
A:ZVS501
|
3.9
|
76.8
|
1.0
|
CG1
|
A:VAL99
|
3.9
|
33.2
|
1.0
|
CAY
|
A:ZVS501
|
4.1
|
66.3
|
1.0
|
OAU
|
A:ZVS501
|
4.1
|
66.1
|
1.0
|
CAM
|
A:ZVS501
|
4.1
|
74.5
|
1.0
|
CBD
|
A:ZVS501
|
4.3
|
69.1
|
1.0
|
CAJ
|
A:ZVS501
|
4.3
|
72.7
|
1.0
|
NBE
|
A:ZVS501
|
4.3
|
72.3
|
1.0
|
CBB
|
A:ZVS501
|
4.3
|
76.3
|
1.0
|
CG2
|
A:VAL99
|
4.5
|
30.6
|
1.0
|
CAI
|
A:ZVS501
|
4.7
|
80.9
|
1.0
|
CB
|
A:VAL99
|
4.9
|
31.7
|
1.0
|
CAH
|
A:ZVS501
|
5.0
|
77.1
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 4bfs
Go back to
Fluorine Binding Sites List in 4bfs
Fluorine binding site 4 out
of 4 in the Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A)
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Mycobacterium Tuberculosis Pank in Complex with A Triazole Inhibitory Compound (1A) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:85.0
occ:1.00
|
FAD
|
A:ZVS501
|
0.0
|
85.0
|
1.0
|
CAX
|
A:ZVS501
|
1.3
|
76.0
|
1.0
|
CAM
|
A:ZVS501
|
2.3
|
74.5
|
1.0
|
CAL
|
A:ZVS501
|
2.4
|
70.6
|
1.0
|
NE
|
A:ARG238
|
2.8
|
58.8
|
1.0
|
CB
|
A:ALA100
|
3.3
|
31.0
|
1.0
|
CZ
|
A:ARG238
|
3.4
|
70.5
|
1.0
|
NH2
|
A:ARG238
|
3.5
|
75.0
|
1.0
|
CD
|
A:ARG238
|
3.6
|
49.2
|
1.0
|
CAO
|
A:ZVS501
|
3.6
|
67.5
|
1.0
|
CAN
|
A:ZVS501
|
3.6
|
70.1
|
1.0
|
CD1
|
A:TYR235
|
3.7
|
40.0
|
1.0
|
CB
|
A:ARG238
|
3.8
|
37.1
|
1.0
|
CG
|
A:ARG238
|
3.8
|
42.0
|
1.0
|
CA
|
A:ALA100
|
3.8
|
34.4
|
1.0
|
CA
|
A:TYR235
|
4.0
|
40.0
|
1.0
|
CAY
|
A:ZVS501
|
4.1
|
66.3
|
1.0
|
N
|
A:ALA100
|
4.3
|
35.6
|
1.0
|
O
|
A:TYR235
|
4.3
|
41.9
|
1.0
|
CE1
|
A:TYR235
|
4.4
|
40.5
|
1.0
|
CG1
|
A:VAL99
|
4.4
|
33.2
|
1.0
|
CG
|
A:TYR235
|
4.5
|
40.3
|
1.0
|
CB
|
A:TYR235
|
4.5
|
39.1
|
1.0
|
NH1
|
A:ARG238
|
4.6
|
66.1
|
1.0
|
CE
|
A:MET242
|
4.7
|
49.4
|
1.0
|
C
|
A:TYR235
|
4.7
|
40.1
|
1.0
|
O
|
A:TRP234
|
4.8
|
42.6
|
1.0
|
N
|
A:TYR235
|
4.8
|
41.8
|
1.0
|
|
Reference:
C.Bjorkelid,
T.Bergfors,
A.K.V.Raichurkar,
K.Mukherjee,
M.Krishnan,
B.Bandodkar,
T.A.Jones.
Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium Tuberculosis Pank J.Biol.Chem. V. 288 18260 2013.
ISSN: ISSN 0021-9258
PubMed: 23661699
DOI: 10.1074/JBC.M113.476473
Page generated: Thu Aug 1 00:12:51 2024
|